Fresenius Kabi Acquires Smart Infusion Pump Phenom Ivenix, Buys mAbxience Stake

In support of its “Vision 2026” plan, drug producer Fresenius Kabi is making two major moves to expand its biopharmaceutical and medtech capabilities. Firstly, to augment its global infusion treatment offerings, FK has committed $240 million in upfront cash...